News

(English) Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing

/カテゴリ: , , /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing October 28, 2024, Shanghai, […]

さらに読む

(English) Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation

/カテゴリ: , /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation Not available.

さらに読む

(English) Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics

/カテゴリ: , /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics SEATTLE, Oct. 9, 2024 /PRNewswire/ — Arbele, a leading innovator […]

さらに読む

(English) Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event

/カテゴリ: , /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event September 30, 2024, Wuhan – Chime Biologics, a leading global CDMO […]

さらに読む

(English) Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024

/カテゴリ: /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024 Recently, at the 3rd Biologics Contract Manufacturing […]

さらに読む

(English) pilot-plant-of-chime-biologics

/カテゴリ: , /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.  pilot-plant-of-chime-biologics No content available

さらに読む

(English) Going Global – Chime Biologics Embraces Innovation and Quality with Partners

/カテゴリ: , /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Going Global-Chime Biologics Embraces Innovation and Quality with Partners Foreign biopharmaceutical companies seek CDMO partners with long-term prospects, technology levels, and […]

さらに読む

(English) Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy

/1 コメント/カテゴリ: , /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Domain Therapeutics and Chime Biologics announce manufacturing agreement to advance novel anti-CCR8 antibody for cancer immunotherapy The agreement combines Domain Therapeutics’ […]

さらに読む

(English) Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry

/カテゴリ: /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics Achieves ISO 27001 Certification to Strengthen Information Security in the CDMO Industry March 7, 2024, Wuhan, China – Chime […]

さらに読む

(English) Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

/1 コメント/カテゴリ: , /作成者:

申し訳ありません、このコンテンツはただ今　Englishと 中文　のみです。 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language. Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and […]

さらに読む
categoryidArraymk-test